Virus teams up with drug to fight tough stomach and pancreatic cancers
Disease control
Recruiting now
This study is testing a new two-part treatment for people with advanced or spreading cancers of the digestive system, like pancreatic or anal cancer. The treatment combines an engineered virus (pelareorep) with an immunotherapy drug (atezolizumab). Researchers want to see if this…
Phase: PHASE1, PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC